← Bank First Corp
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | $15.3m | $25.5m | $26.7m | $38.0m | $45.4m | $45.2m | $74.5m | $65.6m | $71.5m | |
| Net earnings on life insurance | ($549k) | ($608k) | ($625k) | ($741k) | ($768k) | ($925k) | ($1.5m) | ($1.7m) | ($1.6m) | |
| Depreciation and amortization of premises and equipment | $1.1m | $1.1m | $1.3m | $1.5m | $1.8m | $1.7m | $2.1m | $2.3m | $2.4m | |
| Amortization of intangibles | $132k | $756k | $1.1m | $1.6m | $1.4m | $2.3m | $6.3m | $5.8m | $5.0m | |
| Amortization of stock-based compensation | $465k | $556k | $685k | $1.1m | $1.4m | $1.7m | $2.1m | $2.2m | $2.1m | |
| Amortization of unrealized holding gains on securities transferred from available for sale to held to maturity recognized in other comprehensive income, net of tax | ($80k) | ($60k) | ($35k) | ($81k) | ($2k) | ($1k) | ($1k) | — | — | |
| Expense (benefit) from deferred income taxes | $624k | $1.1m | $856k | ($116k) | ($1k) | ($869k) | ($1.7m) | $1.8m | $180k | |
| Loss from sale and disposal of premises and equipment | $0 | $455k | $23k | $178k | ($37k) | $57k | $363k | $375k | $916k | |
| Provision for credit losses | — | — | — | $7.1m | $3.1m | $2.2m | $4.7m | ($800k) | $1.2m | |
| Net accretion of securities | — | — | — | — | $807k | $315k | ($2.4m) | ($3.4m) | ($3.4m) | |
| Accretion of purchase accounting valuations | ($1.6m) | ($6.1m) | ($7.1m) | ($5.5m) | ($1.9m) | ($2.6m) | ($6.9m) | ($4.6m) | ($2.9m) | |
| Net change in deferred loan fees and costs | $651k | $231k | ($216k) | $2.4m | ($1.2m) | ($881k) | ($1.4m) | ($488k) | ($772k) | |
| Change in fair value of MSR and other investments | — | — | $775k | $2.3m | $465k | ($3.0m) | ($693k) | $296k | ($1.3m) | |
| Net (gain) loss on sale of OREO and valuation allowance | ($49k) | $252k | ($73k) | $1.4m | ($20k) | ($146k) | $2.1m | ($694k) | ($159k) | |
| Proceeds from sales of mortgage loans | $51.4m | $37.9m | $86.1m | $215.9m | $295.9m | $85.5m | $74.7m | $118.2m | $169.3m | |
| Originations of mortgage loans held for sale | ($50.9m) | ($37.6m) | ($86.0m) | ($212.2m) | ($290.4m) | ($83.8m) | ($76.2m) | ($117.0m) | ($170.7m) | |
| Gain on sales of mortgage loans | ($895k) | ($617k) | ($1.4m) | ($5.3m) | ($7.4m) | ($1.6m) | ($897k) | ($1.3m) | ($1.8m) | |
| Realized loss on sale of securities | — | — | — | ($3.2m) | $3k | — | $7.9m | $34k | — | |
| Realized gain on sale of UFS | — | — | — | — | — | — | ($38.9m) | — | — | |
| Undistributed earnings of joint venture | — | — | — | — | ($24.7m) | ($25.3m) | ($10.3m) | $17.0m | ($3.9m) | |
| Increase in other assets | $278k | $306k | ($720k) | ($1.9m) | $1.9m | $2.9m | ($2.0m) | ($3.0m) | ($1.2m) | |
| (Decrease) increase in other liabilities | $4.5m | $1.2m | $1.3m | $6.4m | ($5.0m) | ($2.4m) | $15.9m | $5.8m | ($2.5m) | |
| Activity in securities available for sale and held to maturity: Sales | — | — | — | $59.7m | $9.1m | — | $76.0m | $10.2m | — | |
| Activity in securities available for sale and held to maturity: Maturities, prepayments, and calls | — | — | — | $73.5m | $34.0m | $14.7m | $126.7m | $206.4m | $287.3m | |
| Activity in securities available for sale and held to maturity: Purchases | — | — | — | ($28.8m) | ($93.8m) | ($142.4m) | ($26.6m) | ($302.2m) | ($212.7m) | |
| Proceeds from other investments | — | — | — | — | — | — | $248k | — | — | |
| Net increase in loans | ($46.7m) | ($29.2m) | ($36.5m) | ($343.6m) | ($41.7m) | ($198.0m) | ($37.4m) | ($168.9m) | ($84.7m) | |
| Proceeds from sale of UFS | — | — | — | — | — | — | $51.7m | — | — | |
| Proceeds from sale of OREO | $329k | $3.7m | $1.7m | $5.5m | $1.9m | $320k | $1.8m | $3.9m | $900k | |
| Net (purchase) sales of Federal Home Loan Bank ("FHLB") stock | — | — | — | — | — | ($635k) | $262k | ($1.3m) | $79k | |
| Net purchases of Federal Reserve Bank ("FRB") stock | — | $0 | $0 | ($2.8m) | — | ($3.6m) | ($3.9m) | — | — | |
| Proceeds from life insurance | $0 | $152k | $0 | $0 | $265k | — | — | $1.4m | $2.0m | |
| Proceeds from sale of premises and equipment | $0 | $445k | $0 | $284k | $548k | — | — | $2.4m | $1k | |
| Purchases of premises and equipment | ($2.8m) | ($7.9m) | ($7.3m) | ($8.4m) | ($8.7m) | ($6.9m) | ($13.5m) | ($7.2m) | ($11.4m) | |
| Net cash received in business combination | — | $0 | ($9.8m) | $35.3m | $0 | $154.4m | $90.0m | — | — | |
| Net increase (decrease) in deposits | $34.2m | $51.0m | $17.5m | $307.0m | $207.8m | ($72.9m) | ($159.4m) | $228.1m | $34.7m | |
| Net decrease in securities sold under repurchase agreements | ($2.5m) | ($16.1m) | $14.4m | ($10.3m) | $4.7m | $56.1m | ($21.4m) | ($75.7m) | — | |
| Proceeds from advances of notes payable | $3.5m | $0 | $0 | $88.0m | $5.0m | $3.1b | $121.7m | $140.0m | $220.0m | |
| Repayment of notes payable | $0 | ($3.5m) | $0 | ($127.4m) | ($20.4m) | ($3.1b) | ($93.1m) | ($40.0m) | ($245.5m) | |
| Repayment of subordinated notes | — | — | — | — | — | — | ($11.5m) | — | — | |
| Repayment of junior subordinated debentures | — | — | — | — | — | — | ($8.2m) | ($4.1m) | — | |
| Interest | $6.8m | $14.4m | $18.9m | $15.0m | $7.1m | $11.3m | $44.1m | $66.0m | $71.0m | |
| Income taxes | $8.0m | $5.8m | $6.7m | $10.2m | $16.8m | $14.1m | $23.8m | $14.1m | $15.9m | |
| Loans transferred to OREO | $2.3m | $1.3m | $4.9m | $1.9m | — | $24k | — | $412k | — | |
| Closed branch building transferred to OREO | — | — | $0 | $0 | $140k | $1.1m | $2.6m | $1.7m | — | |
| MSR resulting from sale of loans | $428k | $356k | $740k | $1.4m | $1.9m | $771k | $879k | $1.3m | $2.0m | |
| Net cash provided by operating activities | $18.3m | $23.1m | $22.6m | $44.0m | $40.3m | $40.0m | $52.9m | $65.8m | $62.5m | |
| Change in unrealized loss on investment securities available for sale, net of tax | $604k | ($1.4m) | $2.9m | $3.3m | ($2.1m) | ($19.2m) | ($1.1m) | ($639k) | $4.3m | |
| Net cash (used in) provided by investing activities | ($41.4m) | ($30.1m) | ($106.2m) | ($206.0m) | ($93.9m) | ($177.8m) | $269.0m | ($252.9m) | ($16.0m) | |
| Proceeds from sales of common stock | $896k | $1.3m | $0 | $19k | $114k | $114k | $195k | $245k | $737k | |
| Repurchase of common stock | ($3.6m) | ($10.4m) | ($4.2m) | ($4.4m) | ($8.3m) | ($14.3m) | ($10.0m) | ($31.9m) | ($22.0m) | |
| Dividends received from UFS | $915k | $1.5m | $2.1m | $2.1m | $2.6m | — | $1.7m | — | — | |
| Dividends received from Ansay | $964k | $1.4m | $1.3m | $1.7m | $1.8m | — | $1.9m | $2.3m | $2.6m | |
| Dividends paid | ($4.0m) | ($4.5m) | ($5.5m) | ($6.1m) | ($8.7m) | ($7.8m) | ($12.0m) | ($15.6m) | ($52.5m) | |
| Net cash (used in) provided by financing activities | $44.9m | $12.8m | $62.2m | $245.8m | $180.2m | ($39.7m) | ($193.8m) | $201.0m | ($64.6m) | |
| Net (decrease) increase in cash and cash equivalents | $21.8m | $5.8m | ($21.3m) | $83.8m | $126.6m | ($177.5m) | $128.1m | $13.9m | ($18.1m) | |
| Cash and cash equivalents at beginning of year | $80.2m | $102.0m | $107.7m | $86.5m | $296.9m | $119.4m | $247.5m | $261.3m | $243.2m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.